Why Federal Law Is the MPJE Foundation
The MPJE is simultaneously a federal law exam and a state law exam. While your state-specific content varies by jurisdiction, every candidate — no matter which state they are testing in — faces the same core body of federal pharmacy law. Mastering federal law first is the single highest-leverage move you can make in your MPJE preparation.
The following 10 topics are drawn from analysis of recent MPJE exam reports, candidate feedback, and the NABP MPJE competency statements. Time spent on these areas has the highest return on investment.
1. Controlled Substances Act (CSA) — Schedule Rules
The CSA is the single most tested topic on the MPJE, appearing across multiple question formats. Every candidate must have complete command of schedules I–V, including what makes a substance qualify for each, and how dispensing rules differ by schedule.
- Schedule II: No refills. New prescription required for each fill. Written Rx required except for emergency oral orders (must be followed by written Rx within 7 days). No defined federal expiration — many states add 6-month expiration.
- Schedule III–IV: Up to 5 refills within 6 months of issue date. Oral and fax prescriptions permitted.
- Schedule V: Up to 5 refills; some products may be dispensed OTC under state law with logbook requirements.
- Partial fills (CII): Allowed within 60 days for terminally ill or LTCF patients; 2019 rule expanded this for all CII patients.
- Emergency CII oral Rx: Pharmacist must reduce to writing; prescriber must deliver written Rx within 7 days; quantity limited to amount needed for emergency period.
2. DEA Registration Requirements
DEA registration questions appear on virtually every MPJE. Know which form applies to each registrant type, who must register, and what practitioners are exempt.
| Registrant Type | DEA Form | Key Notes |
|---|---|---|
| Retail pharmacy | Form 224 | Renew every 3 years; separate registration per state location |
| Manufacturer/distributor | Form 225 | Must register separately from dispensing |
| Researcher | Form 225 | Required for Schedule I research |
| Ordering Schedule II | Form 222 / CSOS | Paper (222) or electronic (CSOS); buyer and supplier both keep copy 3 years |
| Theft/significant loss | Form 106 | Must report to DEA within 1 business day of discovery |
| Disposal request | Form 41 | Used by registrants to request destruction authorization |
3. HIPAA Privacy Rule — Pharmacy Applications
HIPAA questions focus heavily on when disclosure is permitted WITHOUT patient authorization, and the minimum necessary standard. Know these cold:
- No authorization needed: Treatment, payment, healthcare operations (TPO); public health reporting; law enforcement (limited); abuse/neglect reporting; court orders; workers' comp.
- Authorization always required: Marketing, sale of PHI, most research uses, psychotherapy notes, substance abuse treatment records (also governed by 42 CFR Part 2).
- Minimum necessary: Applies to all disclosures except treatment and patient-requested. Pharmacists must share only the minimum PHI needed for the purpose.
- Patient rights: Right to access records (30-day response), right to amend, right to accounting of disclosures (6 years back), right to restrict certain disclosures.
- Breach notification: Notify affected individuals within 60 days of discovery; notify HHS; notify media if 500+ individuals in a state affected.
4. Prescription Validity Requirements
A valid prescription requires specific elements under federal law. Know which elements are mandatory vs. optional, and what makes a prescription invalid or forged.
- Required elements: Patient full name and address; drug name, strength, quantity; directions for use; prescriber name, address, DEA number (for controlled substances); date issued; prescriber signature
- For CII specifically: Prescriber must manually sign; electronic Rx systems must comply with DEA EPCS standards
- Corresponding responsibility: Pharmacist has a corresponding responsibility to ensure a prescription is issued for a legitimate medical purpose — "red flags" such as unusual quantities, cash-only patients, or out-of-area prescribers must be investigated
- Forged prescriptions: Pharmacist must use reasonable care; not liable if deception not detectable by ordinary scrutiny, but must document due diligence
5. OBRA '90 — Patient Counseling and DUR
OBRA '90 established the legal standard for pharmacist patient counseling and prospective drug utilization review (DUR) for Medicaid patients — which most states have extended to all patients by regulation.
- Prospective DUR: Before dispensing, pharmacist must screen for: drug-drug interactions, therapeutic duplication, incorrect dosage, drug-disease contraindications, drug-allergy interactions, clinical abuse/misuse
- Patient counseling: Pharmacist must offer to counsel on new prescriptions. Counseling includes: drug name and description, route, dosage, duration, special instructions, common side effects, proper storage, what to do for missed doses, refill information
- "Offer to counsel": In most states, documenting a patient's refusal of counseling satisfies the requirement. The offer itself is legally required, not the acceptance.
- Applies to Medicaid: OBRA '90 technically applies to Medicaid. But nearly all state pharmacy acts have adopted equivalent standards for all patients.
6. Poison Prevention Packaging Act (PPPA)
The PPPA requires child-resistant (CR) packaging for most Rx and OTC drugs. MPJE questions focus on exemptions, waivers, and which products are permanently exempt.
- Who can waive CR: Patient can request non-CR in writing or orally (pharmacist must document). Prescriber can authorize non-CR on the prescription.
- Permanently exempt drugs (no CR required): Sublingual nitroglycerin tablets; oral contraceptives in manufacturer's dispensing package; powdered OTC aspirin; some inhalation aerosols; effervescent aspirin; erythromycin ethylsuccinate granules
- Once a non-CR container is dispensed: Pharmacist does not need to re-verify the waiver at each refill if the preference is on file, but good practice is to re-confirm annually
- LTCF exemption: Medications dispensed to long-term care facilities in unit-dose packaging are generally exempt
7. Combat Methamphetamine Epidemic Act (CMEA)
CMEA governs the sale of pseudoephedrine (PSE) and ephedrine — precursor chemicals for methamphetamine. Questions test both the federal limits and the logbook requirements.
- Daily purchase limit: 3.6 grams of base PSE per person per day
- 30-day purchase limit: 9 grams per person per 30 days (7.5 grams for mail-order)
- Storage requirement: Behind-the-counter or in locked cabinet — not accessible to customers without pharmacist/staff involvement
- Logbook: Purchaser must show government ID, sign logbook (or electronic equivalent). Retailer must maintain records for 2 years.
- Products affected: Any product containing PSE, ephedrine, or phenylpropanolamine regardless of OTC status
8. Drug Quality and Security Act (DQSA) — 503A vs. 503B
Compounding regulations are heavily tested. The DQSA created a clear distinction between traditional compounding pharmacies (503A) and outsourcing facilities (503B). Know the key differences.
| Feature | 503A (Traditional) | 503B (Outsourcing Facility) |
|---|---|---|
| Requires patient-specific Rx? | Yes — must have valid Rx or history | No — can compound without patient Rx |
| Can sell to hospitals/clinics? | Limited | Yes — can sell in bulk to healthcare facilities |
| FDA inspection | State-regulated primarily | Subject to federal FDA inspection |
| cGMP compliance | Not required (USP <795>/<797>) | Must comply with cGMP standards |
| Can compound copies of FDA-approved drugs? | Generally no (rare exception) | Yes, if on FDA shortage list |
9. Drug Recall Classifications
The FDA classifies drug recalls into three classes based on health hazard. These are frequently tested in MPJE scenario questions about pharmacist responsibilities.
- Class I Recall: Most severe — reasonable probability that use will cause serious adverse health consequences or death. Examples: contaminated sterile products, incorrect potency.
- Class II Recall: May cause temporary adverse health consequences or probability of serious consequences is remote. Examples: sub-potent products.
- Class III Recall: Unlikely to cause any adverse health consequences. Examples: labeling errors not affecting safety, minor packaging defects.
- Pharmacist duties: Remove recalled product from dispensing stock immediately; notify patients if dispensed; document all actions; return product per recall instructions; do not dispense recalled product even if no alternative available.
10. Ryan Haight Act — Telemedicine Prescribing of Controlled Substances
The Ryan Haight Act regulates online prescribing of controlled substances, a topic that has grown in MPJE frequency with the expansion of telehealth.
- General rule: A prescription for a controlled substance via telemedicine is valid only if the prescriber has conducted at least one in-person medical evaluation of the patient.
- Exceptions: Emergency situations; treatment of a patient by a covering practitioner; Indian Health Service; DEA-registered telemedicine sites; prescriptions issued during a declared public health emergency (PHE) under DEA special registration.
- COVID-19 PHE flexibilities: DEA granted temporary expanded telemedicine prescribing authority during the COVID-19 PHE — know that these flexibilities are temporary and subject to change.
- Pharmacist responsibility: Pharmacist must verify that a valid practitioner-patient relationship exists before dispensing controlled substances from telemedicine prescriptions when questions arise.
Study Strategy: Build Federal Law First
These 10 topics should anchor the first week of your MPJE preparation. Build a condensed one-page reference sheet of the key numbers and thresholds: 7 days, 5 refills, 6 months, 3.6 g/day, 9 g/30 days, Class I/II/III, Forms 222/224/225/106/41. Flashcards work exceptionally well for the quantitative thresholds.
After mastering federal law, shift to your state-specific content in Week 2. State questions build on federal law — understanding the federal framework makes state-specific nuances far easier to absorb. For state-specific practice questions with full legal rationales, PharmacyExam.com remains the most comprehensive resource available for 2026.
💡 Pro Tip
On the actual MPJE, when a question seems to pit state law against federal law, always apply the stricter standard. In pharmacy practice, state law can be more restrictive than federal, and pharmacists are held to the higher standard.